Modulation of ERAP1 activity can generate unique immunopeptidomes in cancer cells, mainly due to altered peptide processing in the ER, but also induce changes in the cellular proteome and metabolic state which may have further effects on tumor cells. Here, ERAP1 is linked to neoplasm.